Longeveron Inc. Common Stock (LGVN) is a publicly traded Healthcare sector company. As of May 21, 2026, LGVN trades at $0.73 with a market cap of $21.06M and a P/E ratio of -0.27. LGVN moved +8.06% today. Year to date, LGVN is +23.64%; over the trailing twelve months it is -47.28%. Its 52-week range spans $0.48 to $2.48. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces LGVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own LGVN include Citadel Advisors. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Longeveron Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $0.73 |
| Market Cap | $21.06M |
| P/E Ratio | -0.27 |
| EPS | $-2.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.48 |
| 52-Week Low | $0.48 |
| Volume | 611 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.39M |
| Net Income | $-15.97M |
| Gross Margin | 78.76% |
3 analysts cover LGVN: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.50.